Palatin Technologies Inc PTN:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
0.73quote price arrow up+0.03 (+4.63%)
Volume
46,950
Close
0.6977quote price arrow down-0.0014 (-0.2003%)
Volume
4,736,669
52 week range
0.35 - 1.30

...

Loading . . .

KEY STATS

  • Open0.6941
  • Day High0.72
  • Day Low0.6005
  • Prev Close0.6991
  • 52 Week High1.30
  • 52 Week High Date02/10/21
  • 52 Week Low0.35
  • 52 Week Low Date03/19/20
  • Market Cap160.49M
  • Shares Out230.03M
  • 10 Day Average Volume4.90M
  • Dividend-
  • Dividend Yield-
  • Beta1.55
  • 1 Year % Change29.8

RATIOS/PROFITABILITY

  • EPS (TTM)-0.12
  • P/E (TTM)-6.01
  • Fwd P/E (NTM)-4.88
  • EBITDA (MRQ)-27.87M
  • ROE (MRQ)-33.43%
  • Revenue (MRQ)-450,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-19,006.72%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/12/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Palatin Technologies Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Palatin Technologies, Inc. (Palatin) is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. The Company’s product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. The melanocortin receptor (MCr) system is hormone driven, with effects on food intake, metabolism...
John Prendergast Ph.D.
Chairman
Carl Spana Ph.D.
President
stephen Wills CPA
Chief Financial Officer
Address
4B Cedarbrook Dr
Cranbury, NJ
08512-3641
United States